Skip to main content
. 2018 Sep 15;19(9):2782. doi: 10.3390/ijms19092782

Figure 14.

Figure 14

Proposed mechanisms underlying the positive therapeutic effects of combined SS31 and mitochondria preserved heart function in a setting of ischemia-reperfusion myocardial injury. The protective effects of combined SS31 and mitochondria on myocardium and heart function are completed by inhibiting inflammation, oxidative stress, cellular apoptosis, DNA/mitochondrial damage, and myocardial fibrosis.